Recent cases

Argos Limited v Argos Systems Inc. [2018] EWCA Civ 22119 October 2018James Mellor QC, Jonathan Hill and Maxwell Keay appeared for the Appellant, Argos Limited. Martin Howe QC and Jaani Riordan appeared for the Respondent, Argos Inc. The Appellant is a well-known consumer goods retailer, based in the UK and trading mainly in the UK and Ireland. The Appellant is the registered proprietor of the EU […]
Walton v Verweij [2018] EWHC 1608 (Ch)28 June 2018Charlotte May QC and Jaani Riordan appeared for the defendant in this trial relating to trade mark infringement and validity, and passing off. The claimants claimed that the defendant had infringed their UK and EU trade marks comprising the word GIORDANO, used in relation to clothing. The defendant denied infringement and counterclaimed for revocation and/or […]
Conversant v Huawei [2018] EWHC 808 (Pat)23 May 2018Adrian Speck QC, Isabel Jamal and Thomas Jones appeared for the Claimant, Conversant, in the Defendants’ challenge to the jurisdiction of the English court. Conversant’s claim is for patent infringement by the Defendants, and seeks the determination of a FRAND licence as part of its claimed relief. The Defendants argued that the English court had no jurisdiction, first on […]
FIL Ltd v Fidelis Underwriting Ltd [2018] EWHC 1097 (Ch)11 May 2018Charlotte May QC appeared for the defendants in this trial relating to trade mark infringement and validity, and passing off. The claimant alleged that the defendants had infringed trade marks containing the word FIDELITY, registered in respect of financial, insurance and investment services, by their use of the sign FIDELIS for insurance underwriting services. The defendants counterclaimed for […]
Opinion of the Advocate General in Teva v Gilead SPC case25 April 2018On 25 April 2018, Advocate General Wathelet gave his opinion in Teva and others v Gilead Case C-121/17, referred to the CJEU by Arnold J last year. This important case, in which the CJEU sat, unusually, in a Grand Chamber, considered again the interpretation of Article 3(a) of the Supplementary Protection Certificate Regulation and the conditions for […]
Community Plant Variety Office: Pixley Berries (Juice) Limited v Lucozade Ribena Suntory Limited26 March 2018Andrew Lykiardopoulos QC appeared on behalf of Lucozade Ribena Suntory before the Community Plant Variety Office in its successful resistance of Pixley Berries’ application for a compulsory licence in respect of the blackcurrant plant variety ‘Ben Starav’ used in Ribena. It is the first time an application for a compulsory licence has been made under Article […]
Illumina Inc v Premaitha Health PLC [2018] EWHC 615 (Pat)19 March 2018Michael Tappin QC, along with Joe Delaney from 3 New Square, appeared for TDL Genetics, The Doctors Laboratory and Ariosa Diagnostics in this application by the two respective sets of Defendants to strike out the Claimants’ claim, or alternatively for summary judgment against the First Claimant. The Defendants argued that the bringing of the claim […]
Glencairn v Dartington Crystal [2018] EWHC 769 (Pat)16 March 2018James Abrahams QC appeared for the Claimants in this application for an interim injunction. The Claimants are the proprietor/ exclusive licensee of a registered design for a drinking glass and applied for an interim injunction against the Defendant, a manufacturer of glass wear. The Defendant had applied to revoke the registered design and for a declaration […]
Frank Industries v Nike [2018] EWCA Civ 49713 March 2018James Abrahams QC appeared for Nike in this appeal against an interim injunction granted by His Honour Judge Hacon. The substantive action relates to Nike’s “Nothing beats a Londoner” campaign, during the course of which Nike used the sign ‘LDNR’, for which the Claimant has registered UK and EU trade marks. HH Judge Hacon granted an […]
Actavis v ICOS & Eli Lilly [2017] EWHC 2880 (Pat)15 February 2018Adrian Speck QC and Tom Jones appeared for Actavis, Teva and Mylan in this application by Lilly and Icos (“Lilly”) for an interim injunction to prevent the launch of generic 2.5 and 5mg tadalafil pending a petition by Lilly to the Supreme Court for permission to appeal. At first instance, Lilly’s patent for a dosing regime concerning the […]